Yatin Suneja
Stock Analyst at Guggenheim
(4.50)
# 275
Out of 5,090 analysts
147
Total ratings
57.25%
Success rate
18.64%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Initiates: Buy | $35 | $13.90 | +151.80% | 1 | Dec 3, 2025 | |
| IFRX InflaRx | Maintains: Buy | $10 → $22 | $1.06 | +1,975.47% | 6 | Nov 10, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $90 → $100 | $44.41 | +125.17% | 14 | Nov 5, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $200 → $205 | $149.22 | +37.38% | 9 | Nov 4, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $815 → $865 | $718.36 | +20.41% | 8 | Oct 29, 2025 | |
| NMRA Neumora Therapeutics | Upgrades: Buy | $14 | $2.22 | +530.63% | 3 | Oct 27, 2025 | |
| RAPT RAPT Therapeutics | Initiates: Buy | $70 | $34.47 | +103.10% | 4 | Oct 27, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $60 | $30.84 | +94.55% | 1 | Oct 27, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $155 → $350 | $247.99 | +41.13% | 3 | Oct 17, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Buy | $101 → $150 | $114.51 | +30.99% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $0.53 | +1,397.57% | 3 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $14.90 | +34.23% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $1,070 | $901.17 | +18.73% | 13 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $21 | $20.97 | +0.14% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $100 | $44.26 | +125.94% | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $19.93 | +276.32% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.55 | +488.24% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $155.51 | +12.53% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.70 | +602.70% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $18 | $11.12 | +61.87% | 2 | Jun 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $14.89 | +94.76% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $12 | $14.58 | -17.70% | 4 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.74 | +301.07% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $22.84 | - | 8 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $39.38 | +14.27% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $20.46 | +119.94% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $27.44 | -27.11% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.32 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $33.45 | +94.32% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $29.45 | +205.60% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.07 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $45.01 | +8.86% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $17.74 | +210.03% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $181.30 | +93.05% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.24 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $16.82 | +42.69% | 1 | May 31, 2022 |
DBV Technologies
Dec 3, 2025
Initiates: Buy
Price Target: $35
Current: $13.90
Upside: +151.80%
InflaRx
Nov 10, 2025
Maintains: Buy
Price Target: $10 → $22
Current: $1.06
Upside: +1,975.47%
AnaptysBio
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $44.41
Upside: +125.17%
Axsome Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $149.22
Upside: +37.38%
Regeneron Pharmaceuticals
Oct 29, 2025
Maintains: Buy
Price Target: $815 → $865
Current: $718.36
Upside: +20.41%
Neumora Therapeutics
Oct 27, 2025
Upgrades: Buy
Price Target: $14
Current: $2.22
Upside: +530.63%
RAPT Therapeutics
Oct 27, 2025
Initiates: Buy
Price Target: $70
Current: $34.47
Upside: +103.10%
Oruka Therapeutics
Oct 27, 2025
Initiates: Buy
Price Target: $60
Current: $30.84
Upside: +94.55%
Praxis Precision Medicines
Oct 17, 2025
Maintains: Buy
Price Target: $155 → $350
Current: $247.99
Upside: +41.13%
ABIVAX Société Anonyme
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $114.51
Upside: +30.99%
Oct 8, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $0.53
Upside: +1,397.57%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $14.90
Upside: +34.23%
Sep 18, 2025
Reiterates: Buy
Price Target: $1,070
Current: $901.17
Upside: +18.73%
Sep 18, 2025
Maintains: Buy
Price Target: $15 → $21
Current: $20.97
Upside: +0.14%
Sep 9, 2025
Maintains: Buy
Price Target: $92 → $100
Current: $44.26
Upside: +125.94%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $19.93
Upside: +276.32%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.55
Upside: +488.24%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $155.51
Upside: +12.53%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $3.70
Upside: +602.70%
Jun 10, 2025
Reinstates: Buy
Price Target: $18
Current: $11.12
Upside: +61.87%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $14.89
Upside: +94.76%
May 2, 2025
Maintains: Buy
Price Target: $18 → $12
Current: $14.58
Upside: -17.70%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $3.74
Upside: +301.07%
Mar 20, 2025
Reiterates: Buy
Price Target: n/a
Current: $22.84
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $39.38
Upside: +14.27%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $20.46
Upside: +119.94%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $27.44
Upside: -27.11%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.32
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $33.45
Upside: +94.32%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $29.45
Upside: +205.60%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.07
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $45.01
Upside: +8.86%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $17.74
Upside: +210.03%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $181.30
Upside: +93.05%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.24
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $16.82
Upside: +42.69%